Invesaro

Stocks GRMN Financial statements

Financial statements

GARMIN LTD financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data GARMIN LTD files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue3,0463,1223,3473,7584,1874,9834,8605,2286,2977,246
Cost of revenue1,3571,3241,3681,5241,7052,0922,0542,2232,6002,989
Gross profit1,6891,7981,9802,2342,4812,8902,8073,0053,6974,256
Research and development4685125686056527798359059941,126
Selling, general and administrative4114384785196247219441,0081,1091,254
Operating expenses1,0561,1141,2011,2881,4271,6721,7791,9132,1032,380
Operating income6336847789461,0541,2191,0281,0921,5941,876
Interest income33.436.947.152.83728.640.877.3114129
Other non-operating income5.7613.444.941.649.2-11.837.1108101138
Pre-tax income6396978239871,1031,2071,0651,2001,6952,015
Income tax121-11.912934.711112591.4-89.3284351
Net income5187096949529921,0829741,2901,4111,664
EBITDA6897448431,0181,1321,3221,1471,2251,7342,029
EPS, basic2.743.773.685.015.195.635.066.747.358.65
EPS, diluted2.733.763.664.995.175.615.046.717.308.59
Shares, basic (weighted)0.191881891900.190.19193191192192
Shares, diluted (weighted)0.191891901910.190.19193192193194
Dividend per share1.532.122.282.442.68

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents8478911,2021,0281,4581,4981,2791,6932,0792,279
Short-term investments183376388348173275421459
Receivables5275915707078498436578159831,253
Inventory4855185627537621,2281,5151,3461,4741,772
Other current assets89.9154121169192329316319354468
Total current assets2,2632,3462,6653,0583,6694,2623,9554,4645,3366,248
Property, plant and equipment4835966647298561,0671,1471,2241,2371,375
Lease right-of-use assets063.694.689.5138144165196
Goodwill225287301467584575568608604760
Long-term investments1,3301,2051,1311,2691,2081,1251,1981,397
Other non-current assets94.410710015919010385.391.110795.9
Total assets4,5254,9485,3836,1677,0317,8547,7318,6049,63110,994
Accounts payable172170205241259370212254359347
Accrued liabilities88.8103113128182211176190211228
Deferred revenue14710396.494.686.987.791.1101111106
Total current liabilities7837929211,0361,1641,4481,2121,3111,5081,720
Lease liabilities049.27670115113135165
Other non-current liabilities1.591.791.850.2815.50.320.360.440.780.63
Total liabilities1,0721,0961,2201,3731,5151,7401,5271,5921,7822,021
Paid-in capital1,8361,8281,8241,8361,8801,9612,0422,1252,2472,369
Retained earnings2,0572,4182,7113,2293,7544,3214,7345,2645,9996,970
Treasury stock-456-469-398-345-320-303-475-331-271-406
Other comprehensive income-36.856.48.4355.9183118-115-65.6-14720.6
Shareholders' equity3,4533,8524,1634,7935,5166,1146,2047,0127,8488,973
Total equity3,4533,8524,1634,7935,5166,1146,2047,0127,8488,973
Total liabilities and equity4,5254,9485,3836,1677,0317,8547,7318,6049,63110,994
Shares outstanding0.190.19189191192193192192192193

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income5187096949529921,0829741,2901,4111,664
Depreciation and amortization55.859.964.871.978.1103119132140153
Stock-based compensation41.344.756.463.480.992.576.8101137166
Deferred income tax3.06-91.235.7-88.36.62-5.44-142-340-89.682.5
Change in receivables9-39.17.29-123-109-19.1167-129-196-223
Change in inventory-2.46-7.5-57.7-17028.7-476-363245-179-218
Change in payables-11.5-17.240.626.21.45109-13128.5121-30.5
Cash from operations7066619206991,1351,0127881,3761,4321,633
Capital expenditures-91-140-156-118-185-308-244-194-194-270
Acquisitions-77.9-90.5-29.2-300-149-20.2-13.5-151
Purchases of investments-588-403-789-1,053-1,509-1,052-171-508-840
Cash from investing-122-194-308-451-261-475-145-333-393-645
Share buybacks-93.2-74.5
Dividends paid-481-383-296-417-451-491-679-559-572-664
Cash from financing-562-448-286-416-462-487-841-637-627-844
Exchange rate effect-8.6626.7-15.8-5.9418.1-10.3
Net change in cash13.744.8310-17443140.1-219414386199
Free cash flow6155217645819507055441,1831,2391,363
Income taxes paid11610667.6160133131185302319317

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to March 28, 2026; growth uses fiscal years. Valuation uses the share price of $294.14 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin59.1%Gross profit / revenue.
Operating margin26.5%Operating income / revenue.
EBITDA margin28.5%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin28.1%Pre-tax income / revenue.
Net margin23.3%Net income / revenue.
FCF margin19.4%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin23.4%Cash from operations / revenue.
Effective tax rate17.2%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)18.7%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)15.9%Net income / average total assets.
Return on invested capital (ROIC)23.4%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue15.5%Research and development expense / revenue.
SG&A / revenue17.2%Selling, general and administrative expense / revenue.
Stock-based pay / revenue2.3%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue4.0%Capital expenditures / revenue.
D&A / revenue2.1%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y15.1%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y14.2%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y11.6%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y15.1%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y14.9%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y11.4%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y17.7%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y22.2%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y12.2%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y17.0%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y20.9%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y12.4%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y17.9%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y19.6%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y10.9%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y17.7%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y19.5%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y10.7%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y14.0%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y27.5%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y7.5%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y10.0%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y35.8%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y7.5%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y14.3%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y13.1%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y10.2%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y14.2%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y12.5%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y9.4%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y0.2%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y0.1%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y298.8%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio4.36xCurrent assets / current liabilities.
Quick ratio2.65x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio1.96x(Cash + short-term investments) / current liabilities.
Liabilities / assets15.4%Total liabilities / total assets.
Working capital$4.62BCurrent assets - current liabilities.
Goodwill and intangibles / assets6.9%(Goodwill + intangible assets) / total assets.
Tangible book value$8.52BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.68xRevenue / average total assets.
Fixed asset turnover5.39xRevenue / average property, plant and equipment.
Inventory turnover1.65xCost of revenue / average inventory.
Days inventory221 days365 x average inventory / cost of revenue.
Receivables turnover7.93xRevenue / average receivables.
Days sales outstanding46 days365 x average receivables / revenue.
Days payables41 days365 x average accounts payable / cost of revenue.
Cash conversion cycle226 daysDays inventory + days sales outstanding - days payables.
FCF conversion83.6%Free cash flow / net income, when net income is positive.
Capex / operating cash flow17.0%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$8.97Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$38.56Revenue / diluted weighted shares.
FCF per share$7.50Free cash flow / diluted weighted shares.
Operating cash flow per share$9.03Cash from operations / diluted weighted shares.
Book value per share$48.06Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$44.17Tangible book value / shares outstanding.
Cash per share$14.00(Cash + short-term investments) / shares outstanding.
Payout ratio39.9%Dividends paid / net income, when net income is positive.
Dividends / FCF47.7%Dividends paid / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$56.73BShare price x shares outstanding.
Enterprise value$54.02BMarket cap + total debt - cash - short-term investments.
P/E32.7xMarket cap / net income. Only when net income is positive.
P/S7.60xMarket cap / revenue.
P/B6.12xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book6.66xMarket cap / tangible book value, when positive.
P/FCF39.1xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF32.4xMarket cap / cash from operations, when positive.
EV/Sales7.24xEnterprise value / revenue.
EV/EBIT27.4xEnterprise value / operating income, when both are positive.
EV/EBITDA25.4xEnterprise value / EBITDA, when both are positive.
EV/FCF37.2xEnterprise value / free cash flow, when both are positive.
FCF yield2.6%Free cash flow / market cap.
Earnings yield3.1%Net income / market cap (the inverse of P/E).
Dividend yield1.2%Dividends paid over the period / market cap.
Shareholder yield1.2%(Dividends paid + share buybacks) / market cap.
PEG1.68xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was GARMIN LTD's revenue in fiscal 2025?

GARMIN LTD reported revenue of $7.25B for fiscal 2025, 15.1% higher than the year before.

Was GARMIN LTD profitable in fiscal 2025?

Yes. Net income was $1.66B, a net margin of 23%.

How much free cash flow did GARMIN LTD generate in fiscal 2025?

Cash from operations of $1.63B minus capital expenditures of $270.4M left free cash flow of $1.36B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to GARMIN LTD